Skip to main content
OpenTrials

Clinical trial condition

Nidovirales Infections

Explore clinical trials studying Nidovirales Infections. Study availability and eligibility vary by location and protocol.

5,124 public trials 294 recruiting studies
Refine in advanced search Browse all conditions

Nidovirales Infections trial results

Recruiting

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

NCT07013474

Conditions
COVID-19, COVID-19 Infection, Coronaviridae Infections, +10 more
Locations
  • Hope Clinical Research, Inc. Canoga Park, California, United States
  • Amicis Research Center - Granada Hills Granada Hills, California, United States
  • Jacobs Medical Center at UC San Diego Health La Jolla, California, United States
  • UC Davis CTSC Clinical Research Center Sacramento, California, United States
View all 152 locations
View Trial Details
Recruiting

Centralization and Oncologic Outcomes in Ovarian Cancer

NCT07075939

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, COVID-19, +30 more
Locations
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Razzini Carpi Carpi, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale di Mirandola Mirandola, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Pavullo nel Frignano Pavullo nel Frignano, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Civile Sassuolo Sassuolo, Modena, Italy
View Trial Details
Recruiting

A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

NCT07536308

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +9 more
Locations
  • The Hope Clinic of Emory University Decatur, Georgia, United States
  • University of Maryland, School of Medicine, Center for Vaccine Development and Global Health Baltimore, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Saint Louis University Center for Vaccine Development St Louis, Missouri, United States
View Trial Details

Related conditions